AU2001287537A1 - Fv constructs with an influenceable affinity for substance that is to be linked - Google Patents
Fv constructs with an influenceable affinity for substance that is to be linkedInfo
- Publication number
- AU2001287537A1 AU2001287537A1 AU2001287537A AU8753701A AU2001287537A1 AU 2001287537 A1 AU2001287537 A1 AU 2001287537A1 AU 2001287537 A AU2001287537 A AU 2001287537A AU 8753701 A AU8753701 A AU 8753701A AU 2001287537 A1 AU2001287537 A1 AU 2001287537A1
- Authority
- AU
- Australia
- Prior art keywords
- constructs
- linked
- affinity
- substance
- influenceable
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2317/00—Immunoglobulins specific features
- C07K2317/60—Immunoglobulins specific features characterized by non-natural combinations of immunoglobulin fragments
- C07K2317/62—Immunoglobulins specific features characterized by non-natural combinations of immunoglobulin fragments comprising only variable region components
- C07K2317/622—Single chain antibody (scFv)
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- Life Sciences & Earth Sciences (AREA)
- Genetics & Genomics (AREA)
- Medicinal Chemistry (AREA)
- Molecular Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Immunology (AREA)
- Peptides Or Proteins (AREA)
- Solid-Sorbent Or Filter-Aiding Compositions (AREA)
- Compounds Of Unknown Constitution (AREA)
Applications Claiming Priority (5)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE10040046 | 2000-08-11 | ||
DE10040046 | 2000-08-11 | ||
DE10044002 | 2000-09-05 | ||
DE10044002A DE10044002A1 (de) | 2000-08-11 | 2000-09-05 | F¶v¶-Konstrukte mit beeinflußbarer Affinität zu einer zu bindenden Substanz |
PCT/DE2001/003098 WO2002014371A1 (fr) | 2000-08-11 | 2001-08-10 | Structures fv presentant une affinite influençable avec une substance a lier |
Publications (1)
Publication Number | Publication Date |
---|---|
AU2001287537A1 true AU2001287537A1 (en) | 2002-02-25 |
Family
ID=26006714
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AU2001287537A Abandoned AU2001287537A1 (en) | 2000-08-11 | 2001-08-10 | Fv constructs with an influenceable affinity for substance that is to be linked |
Country Status (6)
Country | Link |
---|---|
US (1) | US20050054000A1 (fr) |
EP (1) | EP1307490B1 (fr) |
AT (1) | ATE360035T1 (fr) |
AU (1) | AU2001287537A1 (fr) |
DE (1) | DE50112379D1 (fr) |
WO (1) | WO2002014371A1 (fr) |
Families Citing this family (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US7829084B2 (en) * | 2001-01-17 | 2010-11-09 | Trubion Pharmaceuticals, Inc. | Binding constructs and methods for use thereof |
US7754208B2 (en) | 2001-01-17 | 2010-07-13 | Trubion Pharmaceuticals, Inc. | Binding domain-immunoglobulin fusion proteins |
EP2298815B1 (fr) | 2005-07-25 | 2015-03-11 | Emergent Product Development Seattle, LLC | Reduction de lymphocytes B au moyen de molecules de liaison specifique de CD37 et specifique de CD20 |
KR101571027B1 (ko) * | 2006-06-12 | 2015-11-23 | 이머전트 프로덕트 디벨롭먼트 시애틀, 엘엘씨 | 효과기 기능을 갖는 단일쇄 다가 결합 단백질 |
US20090148447A1 (en) * | 2007-07-06 | 2009-06-11 | Trubion Pharmaceuticals, Inc. | Binding Peptides Having a C-terminally Disposed Specific Binding Domain |
WO2009126944A1 (fr) * | 2008-04-11 | 2009-10-15 | Trubion Pharmaceuticals, Inc. | Produits d’immunothérapie de cd37 et combinaison avec un produit chimiothérapique bifonctionnel de celui-ci |
US8647829B2 (en) * | 2009-02-20 | 2014-02-11 | General Electric Company | Switchable affinity binders |
SG10202002577XA (en) | 2015-09-21 | 2020-04-29 | Aptevo Res & Development Llc | Cd3 binding polypeptides |
ES2708657T3 (es) | 2016-07-29 | 2019-04-10 | Miltenyi Biotec Gmbh | Composición y método para afectar la unión de polipéptidos de unión a antígeno a antígenos |
Family Cites Families (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6075010A (en) * | 1992-06-09 | 2000-06-13 | Neorx Corporation | Small molecular weight ligand-hexose containing clearing agents |
US4569794A (en) * | 1984-12-05 | 1986-02-11 | Eli Lilly And Company | Process for purifying proteins and compounds useful in such process |
US5594115A (en) * | 1990-04-09 | 1997-01-14 | Pharmacia & Upjohn Company | Process of purifying recombinant proteins and compounds useful in such process |
US5439829A (en) * | 1991-01-30 | 1995-08-08 | Eli Lilly And Company | Immobilization of biologically active molecules by changing the Oxidation state of a chelated transition metal ion |
US5646001A (en) * | 1991-03-25 | 1997-07-08 | Immunivest Corporation | Affinity-binding separation and release of one or more selected subset of biological entities from a mixed population thereof |
DE69708420T2 (de) * | 1996-09-09 | 2002-07-18 | Rmf Dictagene S.A., Prilly | Herstellung von gereinigten (Poly)Peptiden |
-
2001
- 2001-08-10 DE DE50112379T patent/DE50112379D1/de not_active Expired - Fee Related
- 2001-08-10 EP EP01967009A patent/EP1307490B1/fr not_active Expired - Lifetime
- 2001-08-10 AT AT01967009T patent/ATE360035T1/de not_active IP Right Cessation
- 2001-08-10 WO PCT/DE2001/003098 patent/WO2002014371A1/fr active IP Right Grant
- 2001-08-10 AU AU2001287537A patent/AU2001287537A1/en not_active Abandoned
- 2001-08-10 US US10/344,447 patent/US20050054000A1/en not_active Abandoned
Also Published As
Publication number | Publication date |
---|---|
ATE360035T1 (de) | 2007-05-15 |
EP1307490B1 (fr) | 2007-04-18 |
US20050054000A1 (en) | 2005-03-10 |
DE50112379D1 (de) | 2007-05-31 |
WO2002014371A1 (fr) | 2002-02-21 |
EP1307490A1 (fr) | 2003-05-07 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AU2002235994A1 (en) | Method for producing proteins by fermentation of microorganisms from the thermus family, the protein mixture thus obtained and cosmetic compositions containing same | |
AU2821195A (en) | Cross-reacting monoclonal antibodies specific for e-selectin and p-selectin | |
EP2221317A3 (fr) | Single domain anticorps (dAb) conjugés à PEG | |
AU1843395A (en) | Antibody purification | |
EP3569610A3 (fr) | Molécules à demi-vies longues, compositions et utilisations associées | |
WO2000001815A3 (fr) | Facteurs neurotrophiques | |
WO2003059935A3 (fr) | Methodes de purification d'une proteine | |
IL100460A0 (en) | Method for optimization of binding proteins and nucleic acids encoding a binding protein produced thereby | |
EP2281837A3 (fr) | Domaines se liant à l'antigène issus de poisson | |
AU2001287537A1 (en) | Fv constructs with an influenceable affinity for substance that is to be linked | |
WO2002019963A3 (fr) | Protéines de synthèse stimulant l'érythropoïèse | |
CA2214633A1 (fr) | Purification d'anticorps par une chromatographie d'interaction hydrophobe a ph faible | |
WO1999047536A3 (fr) | Procede permettant de faire la synthese de molecules d'acide nucleique | |
AU1885197A (en) | Antibody variants | |
EP1437368B8 (fr) | Composition pour immobilisation par polymerisation de macromolecules biologiques et procede de fabrication correspondant | |
AU2001239517A1 (en) | Single chain antibody against mutant p53 | |
WO1996031603A3 (fr) | Procedes et compositions pour reguler le niveau de la proteine 'fadd' | |
AU4952097A (en) | Anti-p53 single-chain antibody fragments and their uses | |
WO2002059322A3 (fr) | Compositions et methodes liees a la famille de genes biosynthetiques de la daptomycine | |
AU2002354180A1 (en) | Method of oxidising sulphur compounds present in gasoline, kerosene and diesel fractions | |
EP1162231A3 (fr) | Polybutadiène et procédé de production dudit polybutadiène | |
DE59605545D1 (de) | Alkoholhaltige instant-getränkemischung, ihre herstellung und verwendung | |
WO2003014297A3 (fr) | Compositions et procedes relatifs a la famille multigenique biosynthetique de la daptomycine | |
ATE216778T1 (de) | Verfahren zur herstellung von konjugaten aus einem spezifischen bindungspartner und einem kohlenhydrathaltigen protein | |
AU2002231621A1 (en) | Method of producing antibodies by immunization with conjugates of molecules coupled to charge-modified proteins |